The first half of 2025 was brutal…
The first half of 2025 was brutal for biotech, but [...]
Despite missing its primary…
Despite missing its primary endpoint in a phase 3 study, [...]
Viking Therapeutics has reported…
Viking Therapeutics has reported phase 2 data on its oral [...]
Delays from the Food and Drug…
Delays from the Food and Drug Administration continue to pile [...]
Gene therapy biotech Kriya…
Gene therapy biotech Kriya Therapeutics has secured $313 million in [...]
Genentech’s summer of downsizing…
Genentech’s summer of downsizing and cost-cutting continued this morning, with [...]
After an FDA rejection in May,…
After an FDA rejection in May, Stealth BioTherapeutics has resubmitted [...]
Omeros’ efforts to get its…
Omeros’ efforts to get its transplant drug to market have [...]
Experienced business developer…
Experienced business developer Derek Hicks has been handed the reins [...]
Evotec previously planned to lay…
Evotec previously planned to lay off 400 staffers amid a [...]